Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1980 1
1982 1
1983 1
1984 3
1985 1
1986 4
1987 7
1988 6
1989 6
1990 4
1991 4
1992 2
1993 5
1994 1
1995 8
1996 8
1997 8
1998 15
1999 22
2000 21
2001 19
2002 15
2003 31
2004 32
2005 21
2006 32
2007 28
2008 22
2009 21
2010 26
2011 32
2012 47
2013 37
2014 38
2015 57
2016 44
2017 60
2018 61
2019 67
2020 80
2021 96
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

907 results
Results by year
Filters applied: . Clear all
Page 1
Topoisomerases as anticancer targets.
Delgado JL, Hsieh CM, Chan NL, Hiasa H. Delgado JL, et al. Among authors: chan nl. Biochem J. 2018 Jan 23;475(2):373-398. doi: 10.1042/BCJ20160583. Biochem J. 2018. PMID: 29363591 Free PMC article. Review.
Prevention of Venous Thromboembolism in 2020 and Beyond.
Nicholson M, Chan N, Bhagirath V, Ginsberg J. Nicholson M, et al. Among authors: chan n. J Clin Med. 2020 Aug 1;9(8):2467. doi: 10.3390/jcm9082467. J Clin Med. 2020. PMID: 32752154 Free PMC article. Review.
Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy.
Gao Y, Nihira NT, Bu X, Chu C, Zhang J, Kolodziejczyk A, Fan Y, Chan NT, Ma L, Liu J, Wang D, Dai X, Liu H, Ono M, Nakanishi A, Inuzuka H, North BJ, Huang YH, Sharma S, Geng Y, Xu W, Liu XS, Li L, Miki Y, Sicinski P, Freeman GJ, Wei W. Gao Y, et al. Among authors: chan nt. Nat Cell Biol. 2020 Sep;22(9):1064-1075. doi: 10.1038/s41556-020-0562-4. Epub 2020 Aug 24. Nat Cell Biol. 2020. PMID: 32839551 Free PMC article.
COVID-19 coagulopathy, thrombosis, and bleeding.
Chan NC, Weitz JI. Chan NC, et al. Blood. 2020 Jul 23;136(4):381-383. doi: 10.1182/blood.2020007335. Blood. 2020. PMID: 32702124 Free PMC article. No abstract available.
Pediatric Uveitis.
Chan NS, Choi J, Cheung CMG. Chan NS, et al. Asia Pac J Ophthalmol (Phila). 2018 May-Jun;7(3):192-199. doi: 10.22608/APO.2018116. Epub 2018 Apr 23. Asia Pac J Ophthalmol (Phila). 2018. PMID: 29682916 Review.
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial.
Barcenas CH, Hurvitz SA, Di Palma JA, Bose R, Chien AJ, Iannotti N, Marx G, Brufsky A, Litvak A, Ibrahim E, Alvarez RH, Ruiz-Borrego M, Chan N, Manalo Y, Kellum A, Trudeau M, Thirlwell M, Garcia Saenz J, Hunt D, Bryce R, McCulloch L, Rugo HS, Tripathy D, Chan A; CONTROL Study Investigators. Barcenas CH, et al. Among authors: chan n. Ann Oncol. 2020 Sep;31(9):1223-1230. doi: 10.1016/j.annonc.2020.05.012. Epub 2020 May 25. Ann Oncol. 2020. PMID: 32464281 Free article. Clinical Trial.
Antithrombotic Agents.
Chan NC, Weitz JI. Chan NC, et al. Circ Res. 2019 Feb;124(3):426-436. doi: 10.1161/CIRCRESAHA.118.313155. Circ Res. 2019. PMID: 30702990 Review.
Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.
Bahleda R, Italiano A, Hierro C, Mita A, Cervantes A, Chan N, Awad M, Calvo E, Moreno V, Govindan R, Spira A, Gonzalez M, Zhong B, Santiago-Walker A, Poggesi I, Parekh T, Xie H, Infante J, Tabernero J. Bahleda R, et al. Among authors: chan n. Clin Cancer Res. 2019 Aug 15;25(16):4888-4897. doi: 10.1158/1078-0432.CCR-18-3334. Epub 2019 May 14. Clin Cancer Res. 2019. PMID: 31088831 Free article. Clinical Trial.
907 results